Question follow-through · 107054

Dairy Products: Nutrition

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential financial implications for the dairy and yoghurt manufacturing industry of reformulating products if the revised Nutrient Profiling Model results in yog

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
20 Jan 2026
Target answer date
22 Jan 2026
Answer
29 Jan 2026 · 9 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 20 Jan 2026

    Question tabled

    To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential financial implications for the dairy and yoghurt manufacturing industry of reformulating products if the revised Nutrient Profiling Model results in yog

  2. 22 Jan 2026

    Target answer date

    Date supplied by the official written-questions record.

  3. 29 Jan 2026

    Answer published

    As set out in our 10-Year Health Plan for England: fit for the future, we will take decisive action on the obesity crisis, easing the strain on our National Heath Service and creating the healthiest generation of children ever.As part of this, we are comm...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

No later same-department questions indexed.

This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.